KHIRON LIFE SCIENCES

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2022, KHIRON LIFE SCIENCES has already paid €2.42 in dividends. The last payout was in August 2022.

Financials

In the last year, KHIRON LIFE SCIENCES had revenue of €8.9M and net profit of -€23.05M

(EUR)	2021	YoY
Revenue	8.9M	72.16%
Gross profit	4.43M	1.94%
Net profit	-23.05M	48.66%
EBITDA	-22.29M	54.85%

Fundamentals

Metric	Value
Market capitalization	€2.08K
Number of shares	232.4M
52-week high/low	€0.0000897 - €0.0000009
Dividends	No
Beta	5.43
P/E ratio	-0.20
PEG ratio	0.00
P/B ratio	0.20
P/S ratio	0.73

Company profile

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.